Description
Intaxel 260mg Injection 43.4ml is a specialized oncology treatment, formulated to aid in the management of various types of cancer. This injection contains the active ingredient Docetaxel, a potent chemotherapy agent that inhibits cell growth and division, thereby targeting cancer cells. The solution is administered intravenously under medical supervision and is designed to provide effective control over tumor progression. Its primary use is in the treatment of breast, non-small cell lung, gastric, and head and neck cancers. The 43.4ml vial ensures a sufficient dose for multiple administrations, making it a valuable tool in comprehensive cancer care regimens.
Reviews
There are no reviews yet.